GENinCode (LON:GENI) Trading Up 8.6% – What’s Next?

GENinCode Plc (LON:GENI) shares were up 8.6% during trading on Wednesday . The stock traded as high as GBX 1.14 and last traded at GBX 1.14. Approximately 2,335,945 shares were traded during mid-day trading, a decline of 50% from the average daily volume of 4,717,759 shares. The stock had previously closed at GBX 1.05.

GENinCode Stock Performance

The firm’s fifty day simple moving average is GBX 1.12 and its 200 day simple moving average is GBX 2.18. The company has a market capitalization of £8.27 million, a price-to-earnings ratio of -0.49 and a beta of 0.62. The company has a debt-to-equity ratio of 7.17, a current ratio of 2.80 and a quick ratio of 15.89.

About GENinCode

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.